Gene · 7307
Papers3,382
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 3,382
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A Survival Analysis of Acute Myeloid Leukemia Patients Treated With Intensive Chemotherapy: A Single Center Experience. | Cureus | 2023 | 37731446 | PubTator, text mining | PubMed |
| Clonal Hematopoiesis Defined by Somatic Mutations Infrequently Co-occurs With Mosaic Loss of the Y Chromosome in a Population-based Cohort. | Hemasphere | 2023 | 37720253 | PubTator, text mining | PubMed |
| Spliceosome mutations are associated with clinical response in a phase 1b/2 study of the PLK1 inhibitor onvansertib in combination with decitabine in relapsed or refractory acute myeloid leukemia. | Ann Hematol | 2023 | 37702821 | PubTator, text mining | PubMed |
| A Novel RUNX1 Genetic Variant Identified in a Young Male with Severe Osteoporosis. | JBMR Plus | 2023 | 37701147 | PubTator, text mining | PubMed |
| Isocitrate Dehydrogenase 1 Mutation and Ivosidenib in Patients With Acute Myeloid Leukemia: A Comprehensive Review. | Cureus | 2023 | 37692182 | PubTator, text mining | PubMed |
| Vacuolar ATPase Is a Possible Therapeutic Target in Acute Myeloid Leukemia: Focus on Patient Heterogeneity and Treatment Toxicity. | J Clin Med | 2023 | 37685612 | PubTator, text mining | PubMed |
| Secondary-type mutations do not impact outcome in NPM1-mutated acute myeloid leukemia - implications for the European LeukemiaNet risk classification. | Leukemia | 2023 | 37679502 | PubTator, text mining | PubMed |
| Putting a finger on histidine methylation. | Genes Dev | 2023 | 37673460 | PubTator, text mining | PubMed |
| The molecular profile in patients with polycythemia vera and essential thrombocythemia is dynamic and correlates with disease's phenotype. | Front Oncol | 2023 | 37671053 | PubTator, text mining | PubMed |
| A patient-derived organoid-based study identified an ASO targeting SNORD14E for endometrial cancer through reducing aberrant FOXM1 Expression and β-catenin nuclear accumulation. | J Exp Clin Cancer Res | 2023 | 37667311 | PubTator, text mining | PubMed |
| Single-cell multi-omics identifies chronic inflammation as a driver of TP53-mutant leukemic evolution. | Nat Genet | 2023 | 37666991 | PubTator, text mining | PubMed |
| Molecular basis of RNA-binding and autoregulation by the cancer-associated splicing factor RBM39. | Nat Commun | 2023 | 37666821 | PubTator, text mining | PubMed |
| Patients with telomere biology disorders show context specific somatic mosaic states with high frequency of U2AF1 variants. | Am J Hematol | 2023 | 37665761 | PubTator, text mining | PubMed |
| A globally applicable "triple A" risk model for essential thrombocythemia based on Age, Absolute neutrophil count, and Absolute lymphocyte count. | Am J Hematol | 2023 | 37665758 | PubTator, text mining | PubMed |
| Targeted splicing therapy: new strategies for colorectal cancer. | Front Oncol | 2023 | 37664052 | PubTator, text mining | PubMed |
| The many faces of nodal and splenic marginal zone lymphomas. A report of the 2022 EA4HP/SH lymphoma workshop. | Virchows Arch | 2023 | 37656249 | PubTator, text mining | PubMed |
| Towards understandings of serine/arginine-rich splicing factors. | Acta Pharm Sin B | 2023 | 37655328 | PubTator, text mining | PubMed |
| Case Report: Durable therapy response to Osimertinib in rare EGFR Exon 18 mutated NSCLC. | Front Oncol | 2023 | 37655099 | PubTator, text mining | PubMed |
| A novel germline hyperactivating JAK2 mutation L604F. | Ann Hematol | 2023 | 37639050 | PubTator, text mining | PubMed |
| The clinical relevance of broad mutational screening of myeloproliferative neoplasms at diagnosis. | Front Oncol | 2023 | 37637067 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7307/papers?page=19